To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
67 Newest Publications in nature medicine
rss
matching the following criteria
Finding the tumor copycat: Approximating a human cancer
11-09-2011 | Terry Van Dyke, Nature Medicine, 2011
Finding the tumor copycat: Approximating a human cancer Nature Medicine 16, 976 (2010). doi:10.1038/nm0910-976 Author: Terry Van Dyke
A cancer fate in the hands of a samurai
11-09-2011 | Malcolm A S Moore, Nature Medicine, 2011
A cancer fate in the hands of a samurai Nature Medicine 16, 963 (2010). doi:10.1038/nm0910-963 Author: Malcolm A S Moore Recent studies show that Musashi-2 (MSI2), a molecule that binds RNA, increases proliferation of normal and malignant blood stem cells. In humans, increased ...
Taking thalidomide out of rehab
11-09-2011 | Rosemary J Akhurst, Nature Medicine, 2011
Taking thalidomide out of rehab Nature Medicine 16, 370 (2010). doi:10.1038/nm0410-370 Author: Rosemary J Akhurst Thalidomide, a drug reviled in the 1960s for its teratogenic effects, has been revived in recent years for cancer and leprosy therapy. A study now finds another use for ...
Peering into the aftermath: JAKi rips STAT3 in cancer
26-08-2011 | Florian R Greten; Michael Karin, Nature Medicine, 2011
Peering into the aftermath: JAKi rips STAT3 in cancer Nature Medicine 16, 1085 (2010). doi:10.1038/nm1010-1085 Authors: Florian R Greten & Michael Karin
Peering into the aftermath: The inhospitable host?
26-08-2011 | Robert S Kerbel; John M L Ebos, Nature Medicine, 2011
Peering into the aftermath: The inhospitable host? Nature Medicine 16, 1084 (2010). doi:10.1038/nm1010-1084 Authors: Robert S Kerbel & John M L Ebos Much of how the human host responds to a tumor and to anticancer therapy is still not fully fleshed out. The cytokines and other ...
A small kiss of death for cancer
26-08-2011 | Angelika Eggert; Johannes H Schulte, Nature Medicine, 2011
A small kiss of death for cancer Nature Medicine 16, 1079 (2010). doi:10.1038/nm1010-1079 Authors: Angelika Eggert & Johannes H Schulte The tumor suppressor p53 is inactivated by genetic mutations in many cancers, except for neuroblastoma. New findings show that this cancer ...
Nothing to sneeze at
26-08-2011 | Erica Westly, Nature Medicine, 2011
Nothing to sneeze at Nature Medicine 16, 1063 (2010). doi:10.1038/nm1010-1063 Author: Erica Westly A hundred years after scientists first linked histamine molecules to allergies, the study of histamine pathways is in the midst of a revival, thanks in part to the discovery of a new ...
Finding the tumor copycat: Therapy fails, patients don't
26-08-2011 | Lee M Ellis; Isaiah J Fidler, Nature Medicine, 2011
Finding the tumor copycat: Therapy fails, patients don't Nature Medicine 16, 974 (2010). doi:10.1038/nm0910-974 Authors: Lee M Ellis & Isaiah J Fidler The complexity of human metastatic cancer is difficult to mimic in mouse models. As a consequence, seemingly successful studies in ...
A double agent in cancer: Stopping macrophages wounds tumors
26-08-2011 | Joseph E Qualls; Peter J Murray, Nature Medicine, 2011
A double agent in cancer: Stopping macrophages wounds tumors Nature Medicine 16, 863 (2010). doi:10.1038/nm0810-863 Authors: Joseph E Qualls & Peter J Murray
A double agent in cancer: Deciphering macrophage roles in human tumors
26-08-2011 | Christiana Ruhrberg; Michele De Palma, Nature Medicine, 2011
A double agent in cancer: Deciphering macrophage roles in human tumors Nature Medicine 16, 861 (2010). doi:10.1038/nm0810-861 Authors: Christiana Ruhrberg & Michele De Palma Macrophages engulf microbes and cellular debris to protect us from disease and help repair wounded tissues. ...
Netmeeting
